The STOP-COV project was born from an interdisciplinary collaboration between AXXAM SpA, UniMI ("Luigi Sacco" Hospital) and Vita-Salute San Raffaele University, to counter the SARS-CoV-2 pandemic emergency and, consequently, the clinical syndrome defined Covid-19, through the identification of pharmacological inhibitors of the processes of virus penetration into target cells.
This collaboration will also allow fine-tuning innovative research platforms developed thanks to the increased knowledge of the biology of SARS-CoV-2, and, as a consequence, to contribute to the discovery of powerful and specific drugs for the management of new epidemics caused by coronavirus and from other viruses with similar characteristics of spread.